New company formation (about half of which is biotech) from US research institutions was way up in 2004 (up to >460). In 2003, biotech startup growth in US and Europe slowed, with Denmark and Ireland showing highest relative rates of venture formation. In FY2004, US patent applications also jumped (although this may be due partly to improved reporting procedures); almost one-quarter were utility patents (most biotech patents are utility patents). Only about half of US research institutions reported equity stakes in startups (down from ∼70% in 2003).

Source: Association of University Technology Managers
Source: Association of University Technology Managers
Source: Association of University Technology Managers
Source: Association of University Technology Managers
Source: Critical I